|1.||Birkenhäger, Tom K: 2 articles (12/2015 - 11/2004)|
|2.||Jensen, Catherine L: 2 articles (09/2009 - 10/2007)|
|3.||Fox, Meredith A: 2 articles (09/2009 - 10/2007)|
|4.||Murphy, Dennis L: 2 articles (09/2009 - 10/2007)|
|5.||Dias, Brian G: 2 articles (08/2008 - 09/2003)|
|6.||Vaidya, Vidita A: 2 articles (08/2008 - 09/2003)|
|7.||Duman, Ronald S: 2 articles (06/2008 - 09/2003)|
|8.||Nolen, W A: 2 articles (05/2007 - 10/2003)|
|9.||Thase, Michael E: 2 articles (09/2006 - 01/2003)|
|10.||van den Broek, Walter W: 2 articles (11/2004 - 08/2003)|
|1.||Bipolar Disorder (Mania)
02/01/1992 - "The high rates of response to tranylcypromine in both the initial and crossover double-blind studies document the efficacy of MAOI treatment for anergic bipolar depression. "
07/01/1991 - "The authors propose that the apparently superior efficacy of tranylcypromine in bipolar depression is specifically linked to anergia and reversed neurovegetative symptoms. "
12/01/2015 - "Efficacy of Tranylcypromine in Bipolar Depression: A Systematic Review."
12/01/2015 - "For this systematic review comparing tranylcypromine with placebo or active comparators in bipolar depression, relevant randomized controlled trials were identified from systematic searches of PubMed, EMBASE, and Cochrane library databases. "
12/01/2015 - "This systematic review provides evidence for the efficacy and safety of tranylcypromine treatment in bipolar depression. "
|2.||Major Depressive Disorder (Major Depressive Disorders)
09/01/2006 - "Adult outpatients with nonpsychotic major depressive disorder who had not achieved remission or had withdrawn from treatment because of intolerance in three previous prospective medication trials were randomly assigned to receive open-label treatment with either tranylcypromine (N=58) or extended-release venlafaxine plus mirtazapine (N=51). "
11/01/2004 - "A total of 77 severely depressed in-patients, meeting the DSM-IV criteria for major depressive disorder, who failed to respond to fixed plasma level treatment with either tricyclic antidepressants or fluvoxamine were withdrawn from psychotropic medication and included in a double-blind flexible-dose 5-week comparison of tranylcypromine and phenelzine. "
|3.||Nervous System Diseases (Neurological Disorders)
05/01/2014 - "Recent in vitro findings reveal that pretreatment of cells with tranylcypromine (TCP), a drug widely used in the clinic to treat neurological disorders, restrains HSV-1 gene transcription by inhibiting the histone-modifying enzyme lysine-specific demethylase 1. The present study was designed to examine the anti-HSV-1 efficacy of TCP in vivo because of the paucity of reports on this issue. "
01/01/1982 - "This research was designed to determine whether the convulsion-eliciting action of tranylcypromine (TCP) during bartibal (B) withdrawal was specific to physical dependence on B, and to compare the findings with the action of pentetrazol (PTZ). "
11/02/1963 - "TRANYLCYPROMINE AND CONVULSIONS."
02/01/1983 - "It also inhibited significantly tranylcypromine-induced convulsions, while it failed to inhibit similarly induced hyperthermia. "
12/01/1985 - "It has recently been reported that the concentration of beta-phenylethylamine (PEA) was elevated in the plasma of an individual experiencing convulsions because of an overdose of tranylcypromine. "
04/04/1983 - "Challenge with tranylcypromine (Tcp) during barbital (B) withdrawal induces dose-related clonic-tonic convulsion (C-TC), which is also related to the severity of withdrawal signs and their changes with the passage of time. "
04/01/2007 - "Acute chorea and hyperthermia after concurrent use of modafinil and tranylcypromine."
01/01/1984 - "Hyperthermia developed in tranylcypromine pretreated rats given paroxetine or fluoxetine. "
11/01/2010 - "Serotonin syndrome with severe hyperthermia after ingestion of tranylcypromine combined with serotonin reuptake inhibitors and tyramine-rich food in a case of suicide."
05/01/1967 - "In some of the experiments with pentobarbitone sodium rectal temperature even rose to fever level.2. In anaesthetized as well as in unanaesthetized cats injections of tranylcypromine (0.1-1 mg) into the cerebral ventricles caused a rise in rectal temperature.3. In rabbits, rectal temperature was scarcely affected when surgical anaesthesia was produced by intravenous infusions of pentobarbitone sodium under the same condition in which, in cats, intraperitoneal pentobarbitone sodium produced a deep and long-lasting fall in temperature, i.e. "
01/01/1976 - "Tranylcypromine brought about a marked hyperthermia in hyperthyroid rats but conversely hypothermia in hypothyroid rats, while "MAOI-induced 5-HT and norepinephrine increase, 5-HIAA decrease and tyramine uptake inhibition in the brain" of hyper- and hypothyroid rats were almost to the same in degree as in euthyroid rats."
|1.||Antidepressive Agents (Antidepressants)
|2.||Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
|3.||Monoamine Oxidase (MAO)
|4.||Activities of Daily Living (ADL)